Abstract The Rhesus (Rh) blood group is one of the most complex blood groups known in humans. It has remained of primary importance in obstetrics, being the main cause of hemolytic disease of the newborn (HDN). Anti-D causes the most severe form of HDN. Other Rh allo antibodies that are capable of causing severe HDN include anti-c, which clinically is the most important Rh antigen after the D antigen. We report a case of hemolytic disease of the newborn due to Rh anti-c in an infant of an Rh positive mother.
Introduction
Hemolytic disease of the newborn (HDN) due to Rh isoimmunisation is a serious and potentially fatal condition [1] . Anti-D causes the most severe form of HDN and it used to be the major cause of fetal death [2] . Sensitization to antigens other than D in the CDE system is not uncommon [3] . Anti-c is clinically the most important Rh antigen after anti-D and often causes severe HDN [4] . Properly formulated protocols to screen pregnant women for irregular antibodies need to be imposed to prevent perinatal mortality and morbidity [5] .
Case Report
A term live female baby, adequate for gestation age, weighing 2,630 g was admitted to neonatal unit with respiratory distress. The baby was delivered by caesarean section through thick meconium stained amniotic fluid and cried only after resuscitation. The laboratory investigations were as follows: peripheral blood revealed anaemia, thrombocytopenia, polychromatophilia, erythroblastemia, spherocytosis and reticulocytosis (Figs. 1, 2) Direct Coomb's test was positive (Fig. 3) . Total bilirubin was 25.1 mg%. The baby's blood group was B positive. Mother's blood group was AB positive. In view of the persistent anaemia and hyperbilirubinemia, the blood was tested for atypical antibodies. Anti-c antibodies were found to be positive. The baby was treated with double volume exchange transfusion, immunoglobulins and phototherapy. The baby recovered and was discharged on 20th day (Tables 1, 2) .
Discussion
HDN is a well recognised entity because of the isoimmunisation of Rh negative mother in an Rh positive foetus [5] . The significance of Rh blood group is related to the fact that the Rh antigens are highly immunogenic [2] . The Rh blood group system is one of the most polymorphic and immunogenic systems known in humans [6] . To date, 49 Rh antigens are known. D, C, E, c and e are among the most significant. DCe is the most common haplotype in Caucasians (42 %), Native Americans (44 %) and Asians (70 %). In Blacks, the Dce haplotype is slightly more common. The sequence of amino acids determines the specificity of most of the Rh antigens. The D antigen accounts for 50 % of maternal alloimmunisation [2] .
Whereas most clinically significant blood group sensitisations noted during pregnancy are still secondary to anti-D incompatibility, sensitisation to antigens other than D in the CDE system is not uncommon and can cause severe disease [3] . The widespread use of Rh-D immunoglobulin has led to a relative increase in the non Rh-D isoimmunisation as a cause of HDN [3, 5] . Other Rh allo antibodies that are capable of causing severe HDN include anti-c which clinically is the most important Rh antigen after the D antigen. Moderate disease can be caused by anti-Cw and anti-Cx. Rh allo antibodies that are typically associated with mild HDN include anti-C, anti-E and anti-e [2] . The combination of anti-c and anti-E antigens can cause the occurrence of severe foetal and neonatal haemolytic disease [5] . The frequency of D and non-D antigens differs in different populations with respect to their ethnic origin. The frequency of clinically relevant alloantibodies other than anti-D was 328 per 100,000, of which 191 per 100,000 were at risk of HDN. The most common antibodies were anti-E, followed by anti-K and anti-C. Severe HDN resulting from immunization to antigens other than D and requiring intrauterine or postnatal transfusions developed in 21 of 567 (3.7 %) of the pregnancies that were at risk; the antibodies were anti-K in 11.6 %; anti-c in 8.5 %; anti-E in 1.1 %; and Rh antibodies other than anti-C, anti-D, or anti-E in 3.8 % [7] . Serum bilirubin direct 11.9 1.5
The relative ability of antigen to cause clinically significant HDN has been the focus of debate [8] . In majority of transfusion and antenatal care centres in India and other developing countries, routine antenatal antibody screening is done only for Rh-D negative mothers to screen for anti-D antibodies. Hence there may be a delay in the diagnosis of HDN due to the rarity of antigens. It is recommended that routine red cell antibody screening be done at the first appointment in pregnant mothers and, if no antibodies are detected, once more in the third trimester between 28 and 36 weeks. The first case of HDN due to anti-c antibodies in Rh-D positive mother in India was published in a retrospective diagnosis made in 2007. A case of antenatally diagnosed anti-c antibodies that resulted in severe foetal hydrops with the foetal haplotype cDe/cDe was treated successfully with compatible O-negative and c-negative intrauterine blood transfusions. The baby was treated postnatally with double volume exchange transfusion with the same compatible blood [5] . The management of anti-c isoimmunisation or isoimmunisation with any other irregular red cell antibody is similar to the management of anti-D isoimmunised pregnancy with a specification that blood used for fetal and/or neonatal transfusion should be negative for its respective antibody [3, 5] . In the present case, the baby was treated with double volume exchange transfusion, immunoglobulins and phototherapy and responded well.
Anti-c isoimmunization might cause significant foetal haemolytic disease and HDN. There is paucity of data on the prevalence of irregular antibodies in the Indian population. Blood bank guidelines for screening of maternal serum antibodies in both Rh negative and Rh positive women have to be updated to decrease the occurrence of preventable perinatal morbidity and mortality. Testing for irregular blood group antibodies in pregnancy is necessary for better prediction and early diagnosis of HDN. A close follow-up throughout pregnancy is essential if irregular antibodies are present so that antigen negative compatible blood can be provided in a timely manner for exchange transfusions.
